⌘K

Login Start Free

Home/Filings/4/0001415889-25-003585

4//SEC Filing

ABRAMS MICHAEL S 4

Accession 0001415889-25-003585

CIK 0001719406other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:00 PM ET

Size

5.6 KB

Accession

0001415889-25-003585

Insider Transaction Report

Form 4

Period: 2025-02-07

NRX Pharmaceuticals, Inc.NRXP

ABRAMS MICHAEL S

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2025-02-07+50,000→ 50,000 total
Exercise: $2.94Exp: 2035-02-07→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest in three equal annual installments beginning on February 7, 2026.

Documents

1 file

4
form4-02112025_050201.xmlPrimary

Issuer

NRX Pharmaceuticals, Inc.

CIK 0001719406

Entity typeother

Related Parties

1

filerCIK 0001497702

Filing Metadata

Form type: 4
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 5:00 PM ET
Size: 5.6 KB

View on SEC.gov